Ying Huang

Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China

Yuan Lu, Haibo Zhang, Jiapeng Lu et al. · JAMA Network Open · 2021 · 191 citations · Full text

Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial

Lai Xu, Xiangqian Su, Zirui He et al. · The Lancet Oncology · 2021 · 176 citations

Surgical Oncology, Superiority Trial, Colorectal Surgery +8

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Anne M. Noonan, Matthew R. Farren, Susan Geyer et al. · Molecular Therapy · 2016 · 150 citations · Full text

Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia

Kerry A. Rogers, Ying Huang, Amy S. Ruppert et al. · Blood · 2018 · 107 citations · Full text

Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations

Jennifer A. Woyach, Ying Huang, Kerry A. Rogers et al. · Blood · 2019 · 104 citations